177288-53-8

Upstream product

• 177288-49-2 1-{(3aS,4R,6aR)-6-[2-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-yl}-1H-pyrimidine-2,4-dione 
• 161128-73-0 Methanesulfonic acid (3aR,4S,6aR)-6-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-yl ester 
• 161128-70-7 Acetic acid (3aS,4R,6aS)-4-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-yl ester 
• 161128-71-8 Acetic acid (3aS,4S,6aR)-6-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-yl ester 
• 161128-72-9 (3aS,4S,6aR)-6-[2-(tert-butyldimethylsilanyloxy)ethyl]-4,6a-dihydro-2,2-dimethyl-3aH-cyclopenta[d][1,3]dioxol-4-ol 
• 161128-69-4 (3aS,4R,6aS)-4-[2-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-ol 
• 161128-67-2 ((3aS,4R,6aS)-4-Hydroxy-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-yl)-acetic acid ethyl ester 
• 161128-68-3 (3aS,4R,6aS)-4-(2-Hydroxy-ethyl)-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-ol 
• 104010-72-2 (3aS,6aS)-2,2-dimethyl-3a,6a-dihydro-4H-cyclopenta[d][1,3]dioxol-4-one 
• 177288-52-7 4-Amino-1-{(3aS,4R,6aR)-6-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[1,3]dioxol-4-yl}-1H-pyrimidin-2-one 

Relevant academic research and scientific papers

New neplanocin analogues. 6. Synthesis and potent antiviral activity of 6'-homoneplanocin A

The design, synthesis, and antiviral activities of 6'-homoneplanocin A (HNPA, 3) and its congeners having nucleobases other than adenine, such as 3- deazaadenine (4), guanine (5), thymine (6), and cytosine (7), were described. Starting from the known cyclopentenone derivative 8, the optically active (mesyloxy)cyclopentene derivative 15 was prepared, which was condensed with nucleobases then deprotected to give target compounds 3-7. Of these compounds, HNPA showed an antiviral activity spectrum that was comparable to, and an antiviral specificity that was higher than, that of neplanocin A. HNPA proved particularly active against human cytomegalovirus, vaccinia virus, parainfluenza virus, vesicular stomatitis virus, and arenaviruses, which is compatible with an antiviral action targeted at S-adenosylhomocysteine hydrolase. HNPA appears to be a promising candidate drug for the treatment of these viruses.